This is a snippet of the transcript, sign up to read more.
Remember, I'm not inventing this. If you ask these funders about the percentage of cases they fund, they'll tell you it's less than 5%. In reality, it's 1% or 2%. Some of them might be taking risks, of course. The analogy I often use to describe litigation funding is college admissions. It's like applying to Stanford, which has a 2% acceptance rate. It's the same with litigation funding. You package your case in a certain way, just like you would package a college application. It's not wise to apply only to Stanford, even if your last name is Stanford. College consultants advise you to apply to 15 colleges, including the entire Ivy League, Stanford, and MIT. You hope to get into one and you're satisfied if you do. It's the same with litigation funding.
This is a snippet of the transcript, sign up to read more.
I've seen cases that have won. One of the risks is not only that your case loses. There have been funded cases where you've gone to trial, but instead of getting 50 million in damages, you've got five. You can lose by winning. All this is priced in. The significant variable we need to discuss is insurance. Many funders are now trying to pass their risk to insurance companies, which are significantly larger and can afford to take risks in a way that funders can't, because funders have investors to answer to.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.